Perennial allergic rhinitis in children: efficiency and safety of using «Ergocetal»

Authors

  • T.R. Umanets SI «Institute of pediatrics obstetrics and gynecology named after academic E.M. Lukyanova of the NAMS of Ukraine», Ukraine https://orcid.org/0000-0001-9058-7383
  • V.F. Lapshyn SI «Institute of pediatrics obstetrics and gynecology named after academic E.M. Lukyanova of the NAMS of Ukraine», Ukraine https://orcid.org/0000-0003-1896-1865
  • A.A. Rudnev SI «Institute of pediatrics obstetrics and gynecology named after academic E.M. Lukyanova of the NAMS of Ukraine», Ukraine
  • O.I. Pustovalova SI «Institute of pediatrics obstetrics and gynecology named after academic E.M. Lukyanova of the NAMS of Ukraine», Ukraine https://orcid.org/0000-0002-6908-6688

DOI:

https://doi.org/10.15574/PP.2021.86.12

Keywords:

allergic rhinitis, treatment, levocetirizine

Abstract

Purpose — to evaluate the efficacy and safety of levocetirizine («Ergocetal») in children with perennial allergic rhinitis (PAR).

Materials and methods. 30 children aged 6–16 years with PAR were examined. All children were prescribed levocetirizine («Ergocetal») 5 mg in the form of tablets once a day for a month for the treatment of PAR. The criteria for the effectiveness of the treatment were: regression of the main nasal and ocular symptoms of PAR (rhinorrhea, nasal congestion, nasal itching, sneezing, itching and redness of the eyes) according to the visual analogue scale (VAS); dynamics of nasal eosinophilia in a smearst from the nasal mucosa.

Results. The studies have shown that prescribe of levocetirizine «Ergocetal» in monotherapy for school-age children with mild and intermittent PAR had a positive therapeutic effect on nasal and ocular symptoms, as well as on the intensity of eosinophilic inflammation in the nasal mucosa. Established good tolerance and the absence of side effects of «Ergotal» in the examined children.

Conclusions. Therapeutic efficacy, absence of adverse reactions, high adherence to treatment make it possible to recommend levocetirizine («Ergocetal») as monotherapy for mild and intermittent PAR in school children.

The research was carried out in accordance with the principles of the Helsinki declaration. The study protocol was approved by the Local Ethics Committee of an participating institution. The informed consent of the patient was obtained for conducting the studies.

No conflict of interest was declared by the authors.

References

Arrais M, Lulua O, Quifica F, Rosado-Pinto J, Gama JMR, Taborda-Barata L. (2019, Nov-Dec). Prevalence of asthma, allergic rhinitis and eczema in 6-7-year-old schoolchildren from Luanda, Angola. Allergol Immunopathol (Madr). 47 (6): 523-534. Epub 2019 Feb 10. https://doi.org/10.1016/j.aller.2018.12.002; PMid:30745247

Bousquet J, Schunemann HJ, Togias A, Bachert C, Erhola M, Hellings PW, Klimek L, Pfaar O, Wallace D, Ansotegui I, Agache I, Bedbrook A, Bergmann KC, Bewick M, Bonniaud P, Bosnic-Anticevich S, Bosse I, Bouchard J, Boulet LP, Brozek J, Brusselle G, Calderon MA, Canonica WG, Caraballo L, Cardona V, Casale T, Cecchi L, Chu DK, Costa EM, Cruz AA, Czarlewski W, D'Amato G, Devillier P, Dykewicz M, Ebisawa M, Fauquert JL, Fokkens WJ, Fonseca JA, Fontaine JF, Gemicioglu B, van Wijk RG, Haahtela T, Halken S, Ierodiakonou D, Iinuma T, Ivancevich JC, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Kleine Tebbe J, Kowalski ML, Kuna P, Kvedariene V, La Grutta S, Larenas-Linnemann D, Lau S, Laune D, Le L, Lieberman P, Lodrup Carlsen KC, Lourenco O, Marien G, Carreiro-Martins P, Melen E, Menditto E, Neffen H, Mercier G, Mosgues R, Mullol J, Muraro A, Namazova L, Novellino E, O'Hehir R, Okamoto Y, Ohta K, Park HS, Panzner P, Passalacqua G, Pham-Thi N, Price D, Roberts G, Roche N, Rolland C, Rosario N, Ryan D, Samolinski B, Sanchez-Borges M, Scadding GK, Shamji MH, Sheikh A, Bom AT, Toppila-Salmi S, Tsiligianni I, Valentin-Rostan M, Valiulis A, Valovirta E, Ventura MT, Walker S, Waserman S, Yorgancioglu A, Zuberbier T. (2020 Jan). Allergic Rhinitis and Its Impact on Asthma Working Group. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 145 (1): 70-80. e3. Epub 2019 Oct 15. https://doi.org/10.1016/j.jaci.2019.06.049; PMid:31627910

Brown T. (2019, Dec 1). Diagnosis and Management of Allergic Rhinitis in Children. Pediatr Ann. 48 (12): e485-e488. PMID: 31830288. https://doi.org/10.3928/19382359-20191111-01

Cezmi Akdis. (2015). Global atlas of allergic rhinitis and chronic rhinosinusitis. URL: file:///E:/ENT_Atlas_web.pdf.

Duda L, Okhotnikova O, Sharikadze J, Zuvchenko S. (2019). Comparative analysis of prevalence of the most common allergy diseases in children of the Kyiv region (Ukraine) Georgian Medical News 2019. 291: 53-58. URL: https:ncbi.nlmdov/pubmed/31418731.

Gentile D, Bartholow А, Valovirta Е et al. (2013). Current and Future Directions in Pediatric Allergic Rhinitis. J Allergy Clin Immunol: In Practice. 1 (3): 214-226. https://doi.org/10.1016/j.jaip.2013.03.012; PMid:24565478

Kalmarzi RN, Ataee P, Fathollahpour A, Behzadifar M, Moradi M, Sharifian F, Kalani N, Kooti W. (2020). The Prevalence of Allergic Rhinitis among Iranian Children: A Systematic Review and Meta-Analysis. Endocr Metab Immune Disord Drug Targets. 20 (2): 189-197. https://doi.org/10.2174/1871530319666190515100735; PMid:31113353

Masuda S. (2016, Aug). Epidemiology and clinical feature of allergic rhinitis in children. Arerugi. 65 (8): 990-993. Japanese. doi: 10.15036/arerugi.65.990. PMID: 27616172.

Muraro A. (2017). Allergen Immunotherapy Guidelines. Part 2: Recommendations. EAACI. URL: https://medialibrary.eaaci.org/mediatheque/media.aspx?mediaId=60223&channel=8518.

Papadopoulos NG, Guibas GV. (2016). Rhinitis Subtypes, Endotypes, and Definitions. Immunology and allergy clinics of North America. 36 (2): 215-233. https://doi.org/10.1016/j.iac.2015.12.001; PMid:27083098 PMCid:PMC7127043

Schuler Iv CF, Montejo JM. (2019, Oct). Allergic Rhinitis in Children and Adolescents. Pediatr Clin North Am. 66 (5): 981-993. Epub 2019 Aug 5. https://doi.org/10.1016/j.pcl.2019.06.004; PMid:31466686

Zabolotnyi DI. (2016). Alerhichnyi rynit u ditei. Nats. med. akad. pisliadyplom. osvity im. P.L. Shupyka, In-t otolarynholohii im. O.S. Kolomiichenka NAMN Ukrainy, Nats. dyt. spets. likarnia «Okhmatdyt». Kyiv: Lohos: 215.

Zaikov SV, Hatska DO, Korytska IV. (2015). Poshyrenist alerhichnikh zakhvoriuvan (bronkhialnoi astmy, alerhichnoho rynitu, atopichnoho dermatytu) sered ditei ta molodi Vinnytskoi oblasti (rezultaty 2-ho etapu kliniko-epidemiolohichnoho doslidzhennia). Astma i Alerhiia. 3: 28-34.

Zhang YT, Zhang X, Li PZ. (2017, Jan). Comparison of PedsQL™4.0 and RQLQ scales in the assessment of the quality of life in children with allergic rhinitis. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 31 (1): 27-29. Chinese. doi: 10.13201/j.issn.1001-1781.2017.01.008. PMID: 29774680.

Zheng PJ, Wang JS, Liu GF, Zhang SH, Zhang YY. (2020, Jun 5). Efficacy of levocetirizine for the treatment of children with allergic rhinitis: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 99 (23): e20557. https://doi.org/10.1097/MD.0000000000020557; PMid:32502023 PMCid:PMC7306364

Published

2021-06-26